BeOne Medicines (BEIGF) Asset Utilization Ratio (2016 - 2026)

BeOne Medicines (BEIGF) has 11 years of Asset Utilization Ratio data on file, last reported at 0.69 in Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.69, down 3.44% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.69 (down 3.44% YoY), and the FY2025 annual result was 0.76, up 16.54% from the prior year.
• Asset Utilization Ratio grew to 0.69 in Q1 2026 per BEIGF's latest filing, from 0.68 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.75 in Q2 2025 and troughed at 0.11 in Q1 2022.
• A 5-year average of 0.46 and a median of 0.48 in 2024 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2022 and 2023: Asset Utilization Ratio slipped 29.87% in 2022, then surged 157.0% in 2023.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.23 in 2022, then jumped by 87.09% to 0.43 in 2023, then jumped by 49.41% to 0.65 in 2024, then rose by 4.16% to 0.68 in 2025, then increased by 1.51% to 0.69 in 2026.
• Business Quant data shows BEIGF's Asset Utilization Ratio at 0.69 in Q1 2026, 0.68 in Q4 2025, and 0.71 in Q3 2025.